Allakos Reports Q3 2024 Results and Research Progress - TipRanks
| ALLK Stock | USD 1.03 0.02 1.98% |
About 59% of all Allakos' institutional investors are looking to take a long position. The analysis of the overall investor sentiment regarding Allakos suggests that some traders are interested. Allakos' investing sentiment shows overall attitude of investors towards Allakos.
Allakos |
Allakos Reports Q3 2024 Results and Research Progress TipRanks
Read at news.google.com
 |
Allakos Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Allakos can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Allakos Fundamental Analysis
We analyze Allakos' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Allakos using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Allakos based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Target Price
Target Price Comparative Analysis
Allakos is currently under evaluation in target price category among its peers.
Allakos Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Allakos stock to make a market-neutral strategy. Peer analysis of Allakos could also be used in its relative valuation, which is a method of valuing Allakos by comparing valuation metrics with similar companies.
Peers
Allakos Related Equities
| FATE | Fate Therapeutics | 18.28 | ||||
| SANA | Sana Biotechnology | 9.02 | ||||
| CTMX | CytomX Therapeutics | 3.92 | ||||
| ARVN | Arvinas | 2.85 | ||||
| HRTX | Heron Therapeuti | 2.59 | ||||
| DAWN | Day One | 1.53 | ||||
| BPMC | Blueprint Medicines | 1.35 | ||||
| ASMB | Assembly Biosciences | 1.25 | ||||
| ANNX | Annexon | 0.94 | ||||
| SPRO | Spero Therapeutics | 0.88 | ||||
| CRBU | Caribou Biosciences | 0.45 | ||||
| APLS | Apellis Pharmaceuticals | 0.62 | ||||
| ATRA | Atara Biotherapeutics | 0.65 | ||||
| ALLO | Allogene Therapeutics | 0.79 | ||||
| CRNX | Crinetics Pharmaceuticals | 0.81 | ||||
| RARE | Ultragenyx | 1.04 | ||||
| KURA | Kura Oncology | 1.16 | ||||
| RVMD | Revolution Medicines | 1.25 | ||||
| SGMO | Sangamo Therapeutics | 1.74 | ||||
| RCUS | Arcus Biosciences | 2.28 | ||||
| NXTC | NextCure | 2.50 |
Check out Allakos Hype Analysis, Allakos Correlation and Allakos Performance. For more information on how to buy Allakos Stock please use our How to buy in Allakos Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Allakos. If investors know Allakos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Allakos listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.03) | Return On Assets (0.49) | Return On Equity (1.22) |
The market value of Allakos is measured differently than its book value, which is the value of Allakos that is recorded on the company's balance sheet. Investors also form their own opinion of Allakos' value that differs from its market value or its book value, called intrinsic value, which is Allakos' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Allakos' market value can be influenced by many factors that don't directly affect Allakos' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Allakos' value and its price as these two are different measures arrived at by different means. Investors typically determine if Allakos is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Allakos' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.